Dropped head syndrome with necrotizing myopathy: A drug class effect confirmed by 3 repeated exposures to non ergolinic dopamine agonists, due to l-Dopa phobia
Basal Ganglia · 2015-08 · 5 (2-3) · 47-50
DOI: 10.1016/j.baga.2015.05.002 ↗Kurz gefasst
Fachartikel in der Zeitschrift Basal Ganglia, 2015-08. Verfasst von A. Thomas und 3 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 23 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Thomas, A., Bonanni, L., Muzio, A. D., & Onofrj, M. (2015). Dropped head syndrome with necrotizing myopathy: A drug class effect confirmed by 3 repeated exposures to non ergolinic dopamine agonists, due to l-Dopa phobia. Basal Ganglia, 5(2-3), 47-50. https://doi.org/10.1016/j.baga.2015.05.002
Vancouver
Thomas A, Bonanni L, Muzio AD, Onofrj M. Dropped head syndrome with necrotizing myopathy: A drug class effect confirmed by 3 repeated exposures to non ergolinic dopamine agonists, due to l-Dopa phobia. Basal Ganglia. 2015;5(2-3):47-50. doi:10.1016/j.baga.2015.05.002
BibTeX
@article{Thomas2015,
author = {Thomas, A. and Bonanni, L. and Muzio, A. Di and Onofrj, M.},
title = {Dropped head syndrome with necrotizing myopathy: A drug class effect confirmed by 3 repeated exposures to non ergolinic dopamine agonists, due to l-Dopa phobia},
journal = {Basal Ganglia},
year = {2015},
volume = {5},
number = {2-3},
pages = {47--50},
doi = {10.1016/j.baga.2015.05.002}
}
EUVIMED